CuE (0.5 mg/kg) post-treatment caused substantial reduction in AChE activity (p < .01), glutamate level (p < .001), and enhanced GABA content (p < .05) relative to CuE (0.25 mg/kg) in rats exposed to CH. The gene discussed is ACHE; the disease is cyclic hematopoiesis.